ORGANIZATION

1st Generation Poultices “Just One Example” for Proposal to Scrap Health Coverage for OTC-Like Drugs: Shirakawa

March 26, 2015

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Shuji Shirakawa, vice president of the National Federation of Health Insurance Societies (Kenporen), calls for reviewing the range of health coverage for so-called OTC-like drugs, or ethical drugs with the same active pharmaceutical ingredients available as nonprescription medicines. Mr Shirakawa…

To read the full story

Govt Deregulation Panel Calls for Revisiting 14-Day Prescription Limit
June 17, 2015
Applying Uniform Pricing Rule to Unprofitable but Essential Drugs Difficult: Kenporen Veep
March 26, 2015

ORGANIZATION

Time Ripe for Debate on Drug Spending Macroeconomic Indexing: INES
June 3, 2026
Labor Group Urges MHLW to Support Pharma Talent Development
June 3, 2026
Labor Group Urges Govt to View Pharma as Investment, Not Cost
June 1, 2026
Global Pharma CEOs Urge Japan PM to Boost Support for Innovative Drugs
May 29, 2026
Novartis’ Pullicino to Helm EFPIA Japan from July
May 22, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Are Technical Discussions Enough for Japan’s CEA System?

By Ken Yoshino

Japan is finally launching technical discussions on its cost-effectiveness assessment (CEA) system. A health ministry-funded research group is set to…

COLUMN

The Patient North Star: How Gilead Japan Redefined Innovation

By Philip Carrigan

In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…